LinkedIn image ad examples

Quality wants 30-day readmissions after TEAM episodes. Marketing wants to know if last quarter’s campaign moved new-patient volume. Neither question needs a patient’s name, but both teams make data requests that will sit for months before they get answers because of HIPAA privacy laws. Subsalt lets both teams ask and get answers instantly, without touching PHI.

At #ASHG2026, insitrocytes will present research posters exploring how AI, human genetics, and experimental biology can deepen our understanding of disease and inform therapeutic discovery. Join our team at the American Society of Human Genetics Annual Meeting in Montréal, October 20 to 24: 🔬October 21 | Poster Session I: 2:30 – 4:30 PM → Hari Somineni, Staff Data Scientist: Using multimodal imputation to uncover the genetic architecture of regional fat distribution beyond BMI 🔬October 22 | Poster Session II: 4:15 – 6:15 PM → Jingchunzi Shi, Staff Data Scientist: Applying machine learning to MRI data to enable genetic discovery of human brown adipose tissue → Stephanie See, Associate Director: Combining optical screening and single-cell transcriptomics to identify potential therapeutic intervention points in ALS → Alexis Battle, Distinguished Machine Learning Scientist: Using genetics-guided phenotype imputation to strengthen genetic discovery in age-related macular degeneration without increasing sample size 🔬October 23 | Poster Session III: 2:30 – 4:30 PM → Parker Grosjean, Senior Machine Learning Scientist: Applying AI to retinal imaging data to improve genetic discovery in age-related macular degeneration We look forward to connecting with the human genetics community at #ASHG2026. #HumanGenetics #AI #DrugDiscovery

Most ABA providers sit downstream. They wait for diagnoses. They wait for referrals. But the ones growing fastest? They’ve become the front door for autism care. By integrating a quick, objective assessment into intake, they’re engaging families earlier—without adding clinicians. It’s not about becoming a diagnostic center. It’s about owning the first step.

Nutracore LFP blends directly into nutraceutical formulations, helping reduce the need for sifting, pre-blending and rework. The result? Strong powder flow, consistent fill and reliable performance during capsule and tablet manufacture. Manufacturing made easy Nutracore LFP.

Reduce assembly steps and extra adapters with precision single-use components. Elcam’s Bioprocess Family: Built on decades of engineering experience.

When your tablet press runs smoothly, everything runs better. Nutracore® LFP is an organic lubricant that blends directly into your formulation to support superior flow, reliable die ejection and consistent compression. Partner with Colorcon to simplify your process and keep your solid dose manufacturing on track.

Precision components for sensing, routing, access, and flow control. Meet the Bioprocess Family from Elcam, a trusted source of single-use devices.

Effizienz in der Urologie beginnt beim Behandlungsablauf Volle OP-Pläne, begrenzte Personalkapazitäten und steigende Anforderungen an die Behandlungsqualität: Urologische Einrichtungen müssen ihre vorhandenen Ressourcen möglichst effizient einsetzen. Dabei kommt es nicht allein auf die Dauer eines Eingriffs an. Entscheidend ist der gesamte Behandlungspfad – von der Vorbereitung über den Eingriff bis zur Nachsorge. Welche Rolle kann moderne Lasertechnologie dabei spielen? • Planbarkeit: Standardisierte Behandlungsabläufe können die Organisation urologischer Eingriffe erleichtern. • OP-Effizienz: Geeignete Laserverfahren können dazu beitragen, einzelne Behandlungsschritte effizienter zu gestalten. • Prozessoptimierung: Die Abstimmung von Technologie, Personal und Arbeitsabläufen kann helfen, vorhandene Kapazitäten besser zu nutzen. Für die transurethrale Laserablation TULA® beschreiben die aktuellen GIRFT-Empfehlungen des NHS England (Getting It Right First Time) einen strukturierten Implementierungspfad – von der Patientenselektion über standardisierte Abläufe bis zur Teamorganisation. Damit wird ein reproduzierbares ambulantes Versorgungskonzept aufgezeigt. Der LEONARDO® Duster ist die Thulium-Faserlaser-Plattform (TFL) von biolitec® für modernes Stone Dusting. TFL-Technologien bieten Potenziale für kürzere Eingriffszeiten, effektives Dusting und geringere Materialkosten. In Verbindung mit optimierten Behandlungsabläufen können sie dazu beitragen, medizinische Qualität und Wirtschaftlichkeit miteinander zu verbinden. Moderne Laserurologie ist damit nicht nur eine Frage der medizinischen Technologie, sondern auch ihrer intelligenten Integration in den klinischen Alltag. Erfahren Sie mehr über die Laserlösungen von biolitec® für die moderne Urologie. #Laserurologie #Urologie #Klinikmanagement #Prozessoptimierung #TULA #TFL #biolitec

Cepheid began in 1996 with a belief in a better way. Ten years later, the GeneXpert® system entered the clinical market and helped redefine what molecular diagnostics could be. Today, we celebrate 20 years of GeneXpert innovation and the countless clinicians, laboratorians, and healthcare teams who have used fast, simple, and accessible testing to help improve patient care around the world. And we're just getting started. Always onward. https://lnkd.in/eB2XmVCr #GeneXpert20thAnniversary #Cepheid30 #AlwaysOnward #MolecularDiagnostics

Respiratory testing is not one-size-fits-all. In “Goldilocks Diagnostics: Finding the Right Respiratory Test for the Right Patient,” we explore how diagnostic stewardship can help align respiratory testing with the patient, setting, and clinical question. The timing is especially meaningful as Cepheid expands its respiratory testing portfolio with the U.S. launch of the Xpert® Respiratory Panel, a mid-plex option designed to detect 13 respiratory pathogens when broader insight may help inform care. The goal is to choose the approach that is just right for the clinical question in front of you. Read the article: https://lnkd.in/eyEMR9eN?utm_medium=social-organic&utm_source=linkedin&utm_campaign=2026-NAM-CHILD-SOCIAL-BRAND-Insight-Hub&LeadCampaignID=701Nu00000fKYHPIA4 #RespiratoryTesting #DiagnosticStewardship #DiagnosticExcellence #MolecularDiagnostics #Cepheid IVD. In vitro diagnostic medical device. May not be available in all countries

Efter knäkirurgi kan smärta och stelhet göra det svårt för patienten att fullfölja sin rehabilitering hemma. Kinetec Spectra Essential™ CPM-maskin hjälper patienter att genomföra tidig, kontrollerad rörelseträning i hemmet och kan användas som ett komplement till fysioterapi för att snabbare återgå till vardagen. ✔ Tidig mobilisering av knäleden ✔ Daglig rörelseträning utan egen ansträngning ✔ Uthyrning direkt till privatpersoner Skapa rätt förutsättningar för effektiv knärehab!

𝗧𝗵𝗲 𝗻𝗲𝘅𝘁 𝗯𝗶𝗴 𝘀𝘁𝗲𝗽 𝗶𝗻 𝗵𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗶𝘀𝗻'𝘁 𝗷𝘂𝘀𝘁 𝗮𝗯𝗼𝘂𝘁 𝘄𝗵𝗮𝘁 𝘀𝗰𝗶𝗲𝗻𝗰𝗲 𝗰𝗮𝗻 𝗮𝗰𝗵𝗶𝗲𝘃𝗲. 𝗜𝘁 𝗶𝘀 𝗮𝗯𝗼𝘂𝘁 𝗺𝗮𝗸𝗶𝗻𝗴 𝘁𝗵𝗮𝘁 𝗽𝗿𝗼𝗴𝗿𝗲𝘀𝘀 𝘄𝗼𝗿𝗸 𝗳𝗼𝗿 𝗽𝗮𝘁𝗶𝗲𝗻𝘁𝘀. Across three days of discussions at the World Health Summit on global health, innovation and collaboration, there was one consensus: scientific progress alone does not make healthcare systems more resilient. What matters is whether that progress reaches patients. I was particularly honoured to contribute to Daiichi Sankyo's session on 𝘞𝘰𝘮𝘦𝘯'𝘴 𝘏𝘦𝘢𝘭𝘵𝘩 𝘢𝘵 𝘵𝘩𝘦 𝘊𝘰𝘳𝘦 𝘰𝘧 𝘙𝘦𝘴𝘪𝘭𝘪𝘦𝘯𝘤𝘦. From my experience as a physician, I know that even the most promising medical advances can only make a difference when the conditions around care are right. In breast cancer, for example, we have made remarkable progress. Yet across Europe, significant disparities remain in screening, timely diagnosis, biomarker testing and access to innovative treatments. At the IFPMA roundtable on trust in science, we explored another dimension of the same challenge: 𝗧𝗿𝘂𝘀𝘁 𝗶𝘀 𝗻𝗼𝘁 𝗲𝗮𝗿𝗻𝗲𝗱 𝘁𝗵𝗿𝗼𝘂𝗴𝗵 𝘀𝗰𝗶𝗲𝗻𝘁𝗶𝗳𝗶𝗰 𝗯𝗿𝗲𝗮𝗸𝘁𝗵𝗿𝗼𝘂𝗴𝗵𝘀 𝗮𝗹𝗼𝗻𝗲. 𝗜𝘁 𝗴𝗿𝗼𝘄𝘀 𝘄𝗵𝗲𝗻 𝗽𝗮𝘁𝗶𝗲𝗻𝘁𝘀 𝗲𝘅𝗽𝗲𝗿𝗶𝗲𝗻𝗰𝗲 𝘁𝗵𝗲𝗶𝗿 𝗯𝗲𝗻𝗲𝗳𝗶𝘁𝘀. For me, these discussions reinforced something fundamental: 𝘁𝗵𝗲 𝗽𝗵𝗮𝗿𝗺𝗮𝗰𝗲𝘂𝘁𝗶𝗰𝗮𝗹 𝗶𝗻𝗱𝘂𝘀𝘁𝗿𝘆'𝘀 𝗿𝗲𝘀𝗽𝗼𝗻𝘀𝗶𝗯𝗶𝗹𝗶𝘁𝘆 𝗴𝗼𝗲𝘀 𝗯𝗲𝘆𝗼𝗻𝗱 𝗱𝗲𝘃𝗲𝗹𝗼𝗽𝗶𝗻𝗴 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝘃𝗲 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲𝘀. We also have a role to play in connecting science, policy and clinical practice – working with partners across the healthcare ecosystem to turn progress into better outcomes. Thank you to everyone who contributed to these important conversations, and to my Daiichi Sankyo colleagues for making our engagement possible.

We are at NVIDIA GTC (GPU Technology Conference) in Berlin, and today Dawn Health, NVIDIA Healthcare, Microsoft for Healthcare, and Merck Healthcare proudly announce a collaboration to redefine the future of Patient Support Programs (PSPs). The four-way collaboration, the first-of-its-kind within patient support services, is building a novel agentic care experience available to people living with chronic disease, one that is personalized to each patients individual disease state, with access to a nurse or healthcare provider whenever it is needed. Merck Healthcare brings the patient insights, clinical, and pharmaceutical expertise, NVIDIA the technologies and AI reasoning models, and Microsoft the Azure Cloud and AI services. Dawn Health leads product development, regulatory work, and the human-centred design of the patient-facing application on the Dawn Platform. Kimberly Powell, Vice President and General Manager, Healthcare at NVIDIA, will introduce this vision on today’s session, Turning AI Into the Infrastructure Advancing Human Health, happening at NVIDIA GTC, Berlin, at 2:30pm CEST. If you are at NVIDA GTC this week, or evaluating the future of your own patient support programs, I would love to have a chat. Link to the full announcement: https://lnkd.in/dwVGkk_p

Great few days at NVIDIA GTC Berlin, with insightful sessions and discussions on AI and especially in life sciences and healthcare. 🚀 A major highlight was announcing our strategic four-way collaboration between Dawn HealthDawn Health, Merck Healthcare, MicrosoftMerck Healthcare, Microsoft and NVIDIA to redefine Patient Support Programs through AI-enabled, personalised and scalable patient support. A great example of moving beyond AI potential to creating real value for patients and healthcare professionals. Great to share this milestone with Emre Ozcan, PhD, Alexander Mandix Hansen, Wesley Snijders, Johannes Munding, Jantje Rees, Cedric SteenbekeCedric Steenbeke, Nelly Tian CodeToSaveLives #NVIDIAGTC #HealthcareAI #PatientSupport #DigitalHealth

”Det är skönt att alla kommer använda samma system.” Så säger Malin Dolk Samuelsson, biträdande verksamhetschef på Frösjö Vårdcentral i Gnesta, om att fler vårdcentraler i Region Sörmland snart ska börja använda Doctrin. I augusti stod det klart att Region Sörmland Doctrin som ny teknisk lösning för sina digitala vårdkontakter och nu pågår implementeringen. För Frösjö, som har använt Doctrin sedan 2019, innebär det nya möjligheter att utbyta erfarenheter och utveckla sina digitala arbetssätt tillsammans med andra vårdcentraler. Vi har pratat med Malin om deras erfarenheter och vad hon ser fram emot när fler verksamheter i regionen börjar använda samma plattform. Länk till intervjun hittar du i kommentarerna 💬

Viral Arthritis/Tenosynovitis is a force to be reckoned with. Caused by Avian reovirus, it strikes where it hurts - targeting the flock’s tendons and joints and making it harder for birds to stay on their feet. And this villain has more than one way in. With both horizontal and vertical transmission, it can spread through direct contact and from infected breeders to the next generation. Every flock needs a hero that can take it on. Meet VIR 119 - the telekinetic one, always one step ahead of Viral Arthritis/Tenosynovitis. A freeze-dried live vaccine - Viral Arthritis/Tenosynovitis (Reo), strain S1133 - helping protect the flock and keep it healthy and on its feet Heroism is taking action when it matters.

Something new is coming on October 28, and we can't wait to share it with you! Empatica was founded on the idea that healthcare technology should feel friendly, caring, and human. That belief has shaped our work in epilepsy, where we help people feel more independent and their families feel more at ease. It also guides how we support researchers and pharmaceutical companies, whose work with our wearables and digital biomarkers spans a wide range of health conditions. On October 28, we’re introducing a new way to monitor Parkinson's, bringing our FDA-cleared, clinically validated technology directly to people at home. These algorithms are backed by more than 70 peer-reviewed publications and used across more than 150 hospitals and clinical sites worldwide. Our goal is to help people bring more of their everyday experience into view, understand how things change over time, and share a clearer picture with the people supporting their care. Stay tuned, and we look forward to sharing more next week! 👉 Learn more: https://lnkd.in/dvUmP7Cp #Parkinsons #ParkinsonsDisease #DigitalHealth

Selecting the optimal platform for RNA bioanalysis is essential in program development. Leverage BioAgilytix LC/MS, PCR & hELISA platforms to obtain the data you need to advance your RNA therapeutic.

October is ADHD Awareness Month 🧠 Ever walk into a room and immediately forget why you're there? 🤔 Start one task... then another... then another... and somehow finish none of them? Constantly tell yourself,"I'll do it in a minute"? Most of us experience moments like these from time to time. But for some people, challenges with attention, focus, organisation, impulsivity or feeling overwhelmed can have a much bigger impact on everyday life. If you've been wondering whether ADHD could be part of the picture, seeking an assessment can help provide clarity, understanding and access to the right support 💚 At Emerald Urgent Care, we offer comprehensive ADHD assessments for both children and adults, with virtual and face-to-face appointments available. We also offer a free consultation to discuss your concerns and the assessment process. 👉 Learn more or book your consultation today: https://lnkd.in/eGSUiUfk

Why choose LC/MS to analyze the PK of large molecules? Lynn Kamen, PhD and Dave Beyerlein cover the regulatory considerations and where LC/MS delivers the most value.

Dobra atmosfera w pracy nie tworzy się sama - budujemy ją wspólnie każdego dnia. Dlatego w Chiesi chcemy nie tylko słuchać głosu naszych pracowników, ale też przekładać ich opinie i potrzeby na konkretne działania. Jedną z takich inicjatyw jest „Mniej spiny, więcej współpracy” – projekt, który ma wspierać dobrą atmosferę, otwartość i współpracę w naszej codziennej pracy. Jego kierunek również chcemy wypracować razem, dlatego zaprosiliśmy pracowników Chiesi Poland do podzielenia się opiniami i pomysłami na to, co możemy robić jeszcze lepiej. Chcemy, żeby ta inicjatywa przełożyła się na codzienne relacje i sposób współpracy w organizacji tak, aby wszystkim pracowało się po prostu lepiej 😊.

🧠 What if perfusion imaging could help guide decisions during neurointerventions?Join us for an upcoming webinar with Prof. Johannes Kaesmacher, exploring how flat-panel perfusion imaging is opening new possibilities for intraprocedural assessment and clinical decision-making. 🎙️ "Tissue Matters: Flat Panel Perfusion Imaging during Neurointerventions" Discover how intraprocedural perfusion imaging can provide valuable insights into tissue perfusion directly in the angio suite, supporting more informed, real-time decisions during neurointerventional procedures. 📅 Tuesday, November 24, 2026 🕕 18:00–19:00 CET (Europe) 🕕 12:00–13:00 ET (North America) 💻 Online webinar 🔗 Register now: https://lnkd.in/egCmQgP3 Don't miss this opportunity to explore the evolving role of perfusion imaging in neurointerventional care! 🌐 Read more: https://lnkd.in/ek-fYpBf #CercareMedical #PerfusionImaging #Neurointervention #FlatPanelCT #ConeBeamCT #StrokeImaging #Neuroimaging #Webinar

One failed antibody. Weeks of progress gone. Poor-performing antibodies contribute to over $350M in wasted resources annually, and irreproducible research costs the US $28B a year. Download the infographic to see how purpose-built, validated reagents help you scale from single-plex to multiomics with data you can trust.

From custom labeling to bulk quantities and tailored formulations, discover how top-cited reagents and services from CST can support your clients’ assay workflows.